Publishing research using ab3329? Please let us know so that we can cite the reference in this datasheet.

ab3329 has been referenced in 29 publications.

  • Chen C  et al. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biol 20:390-401 (2019). PubMed: 30412827
  • Li FD  et al. Ablation and Inhibition of the Immunoproteasome Catalytic Subunit LMP7 Attenuate Experimental Abdominal Aortic Aneurysm Formation in Mice. J Immunol 202:1176-1185 (2019). PubMed: 30642978
  • Lee MJ  et al. H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth. Sci Rep 9:4089 (2019). PubMed: 30858500
  • Yin J  et al. Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits ß5i. Cell Death Dis 9:1031 (2018). PubMed: 30301930
  • Adelöf J  et al. PA28aß overexpression enhances learning and memory of female mice without inducing 20S proteasome activity. BMC Neurosci 19:70 (2018). PubMed: 30400847
  • Ramos de Carvalho JE  et al. Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells. Biochem Biophys Rep 13:83-92 (2018). PubMed: 29387813
  • Ugras S  et al. Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in a-Synuclein Aggregation Disorders. EBioMedicine 31:307-319 (2018). WB, IHC-P ; Mouse, Human . PubMed: 29759483
  • Moritz KE  et al. The role of the immunoproteasome in interferon-?-mediated microglial activation. Sci Rep 7:9365 (2017). PubMed: 28839214
  • Textor A  et al. Preventing tumor escape by targeting a post-proteasomal trimming independent epitope. J Exp Med 213:2333-2348 (2016). PubMed: 27697836
  • Rouette A  et al. Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers. Sci Rep 6:34019 (2016). WB ; Human . PubMed: 27659694
  • Woods K  et al. Mismatch in epitope specificities between IFN? inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma. J Immunother Cancer 4:10 (2016). PubMed: 26885372
  • Chen S  et al. Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages. Cell Death Differ 23:1026-37 (2016). PubMed: 26990663
  • Pickering AM  et al. Lifespan of mice and primates correlates with immunoproteasome expression. J Clin Invest 125:2059-68 (2015). PubMed: 25866968
  • Tertipis N  et al. Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome. Transl Oncol 8:10-7 (2015). PubMed: 25749172
  • Chen X  et al. Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke. Cell Death Dis 6:e1626 (2015). ICC/IF ; Rat . PubMed: 25633295
  • Ren H  et al. Inhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice. Sci Rep 5:15730 (2015). PubMed: 26508670
  • Pla A  et al. TLR4 mediates the impairment of ubiquitin-proteasome and autophagy-lysosome pathways induced by ethanol treatment in brain. Cell Death Dis 5:e1066 (2014). WB ; Mouse . PubMed: 24556681
  • Camargo R  et al. Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells. PLoS One 9:e95977 (2014). WB ; Human . PubMed: 24752321
  • Del Campo AB  et al. Adenovirus expressing ß2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition. Cancer Gene Ther N/A:N/A (2014). PubMed: 24971583
  • Ferrington DA  et al. Corneal wound healing is compromised by immunoproteasome deficiency. PLoS One 8:e54347 (2013). ICC/IF ; Mouse . PubMed: 23365662
  • Giannini C  et al. Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain. PLoS One 8:e64042 (2013). WB ; Rat . PubMed: 23667697
  • Wehenkel M  et al. A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice. Br J Cancer 107:53-62 (2012). WB ; Human . PubMed: 22677907
  • Sarrabayrouse G  et al. Melanoma cells treated with GGTI and IFN-gamma allow murine vaccination and enhance cytotoxic response against human melanoma cells. PLoS One 5:e9043 (2010). WB ; Human . PubMed: 20140259
  • Hensley SE  et al. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol 184:4115-22 (2010). WB ; Mouse . PubMed: 20228196
  • Martini M  et al. IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine 28:3548-57 (2010). WB ; Mouse . PubMed: 20304037
  • Cai ZP  et al. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J : (2008). PubMed: 18728217
  • Ahtoniemi T  et al. Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis. Mol Pharmacol 71:30-7 (2007). PubMed: 17008387
  • Pang KC  et al. Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses. J Immunol 177:7680-8 (2006). WB ; Mouse . PubMed: 17114438
  • Tilkin-Mariamé AF  et al. Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression. FASEB J 19:1513-5 (2005). PubMed: 15990392

For licensing inquiries, please contact

Sign up